References
- BrayFFerlayJSoerjomataramIGlobal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin201868639442430207593
- KikuchiSTsutsumiOKobayashiNDoes gastrojejunostomy for unresectable cancer of the gastric antrum offer satisfactory palliation?Hepatogastroenterology1999462558458710228865
- LimSMuhsBEMarcusSGResults following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?J Surg Oncol200795211812217262741
- AmaralLMendesJMartinsPSurvival benefits of palliative gastric cancer resection – a regional center experienceHepatogastroenterology2012591171651165622683985
- MaharALCoburnNGSinghSLawCHelyerLKA systematic review of surgery for non-curative gastric cancerGastric Cancer201215S1125137
- IkeguchiMMiyataniKTakayaSRole of surgery in the management for gastric cancer with synchronous distant metastasesIndian J Surg Oncol201671323627065679
- KuligPSierzegaMKowalczykTKolodziejczykPKuligJNon-curative gastrectomy for metastatic gastric cancer: rationale and long-term outcome in multicenter settingsEur J Surg Oncol201238649049622381671
- CunninghamDStarlingNRaoSCapecitabine and oxaliplatin for advanced esophagogastric cancerN Engl J Med20083581364618172173
- KoizumiWNaraharaHHaraTS-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (spirits trial): a phase III trialLancet Oncol20089321522118282805
- van CutsemEMoiseyenkoVMTjulandinSPhase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study GroupJ Clin Oncol200624314991499717075117
- KangYKKangWKShinDBCapecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trialAnn Oncol200920466667319153121
- BangY-Jvan CutsemEFeyereislovaATrastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialLancet2010376974268769720728210
- FujitaniKYangHKMizusawaJGastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trialLancet Oncol201617330931826822397
- WashingtonK7th edition of the AJCC cancer staging manual: stomachAnn Surg Oncol201017123077307920882416
- EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
- Al-BatranSEHomannNPauligkCEffect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trialJAMA Oncol2017391237124428448662
- TakemuraNSaiuraAKogaRLong-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resectionsLangenbecks Arch Surg2012397695195722615045
- MarkarSRMikhailSMalietzisGInfluence of surgical resection of hepatic metastases from gastric adenocarcinoma on long-term survival: systematic review and pooled analysisAnn Surg201626361092110126797324
- GillamsAKhanZOsbornPLeesWSurvival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastasesCardiovasc Intervent Radiol201336372473023070108
- CarpizoDRD’AngelicaMLiver resection for metastatic colorectal cancer in the presence of extrahepatic diseaseAnn Surg Oncol20091692411242119554376
- SalahSWatanabeKParkJSRepeated resection of colorectal cancer pulmonary oligometastases: pooled analysis and prognostic assessmentAnn Surg Oncol20132061955196123334254
- ChiuC-FYangH-RYangM-DPalliative gastrectomy prolongs survival of metastatic gastric cancer patients with normal preoperative CEA or CA19-9 values: a retrospective cohort studyGastroenter Res Pract20162016519
- ShimadaHNoieTOhashiMObaKTakahashiYClinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the task Force of the Japanese Gastric Cancer associationGastric Cancer2014171263323572188